Jupiter Research Capital (Asia) Ltd’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,432
Closed -$33.8K – 775
2026
Q2
$33.8K Buy
+15,432
New +$45.6K ﹤0.01% 688

Other funds holding CMPX

Jupiter Research Capital (Asia) Ltd's CMPX Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Compass Therapeutics (CMPX) in Q3 2026, closing a stake of 15,432 shares — an estimated $33.8K sold.

Jupiter Research Capital (Asia) Ltd first reported a position in CMPX in Q2 2026 and held it in 1 quarter. The position peaked at $33.8K in Q2 2026. 164 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Compass Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 15,432 Compass Therapeutics shares in Q3 2026, an estimated $33.8K.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Compass Therapeutics in Q2 2026 and held it in 1 quarter.
  • Jupiter Research Capital (Asia) Ltd's Compass Therapeutics position peaked at $33.8K in Q2 2026.
  • 164 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.